The Industrial Products group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Sandvik AB (SDVKY) is a stock that can certainly grab ...

Aoris Investment Management, a specialist international equity manager, released its Q4 2024 investor letter. In 2024, ...

Dios Fastigheter AB reported its fourth-quarter 2024 earnings, exceeding analysts' expectations with an earnings per share (EPS) of 2.3, compared to the forecasted 1.49. Despite this significant ...

Sweden’s state-owned pension investors, collectively known as the AP Funds, have fully written down their entire investment in bankrupt battery maker Northvolt AB.

Anheuser-Busch InBev's performance has been a disaster for shareholders in recent years. Click here to learn why BUD stock is ...

Jefferies analyst Cole Hathorn upgraded SSAB AB (SSAAY) to Buy from Hold with a price target of SEK 64, up from SEK 57. The company’s fiscal ...

If you already hold an eligible investment account with Charles Schwab and want ways to grow your investment contributions, the Schwab Investor Card® from American Express* could be a good option.

Activist investor Cevian Partners will remain invested in ABB , it said on Thursday, despite the departure of managing partner Lars Forberg from the engineering company's board.

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

STOCKHOLM—Investor INVE.B1.62%increase; green up pointing triangle AB posted a negative total shareholder return for the fourth quarter of 2024 amid an uncertain global macroeconomic picture ...

The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug last month and lower-than-expected sales figures from Eli Lilly for two ...